Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

BeiGene describes BTK-targeting PROTACs

Nov. 23, 2021

Iomx Therapeutics divulges new SIK2/SIK3 inhibitors

Nov. 23, 2021

U.S. researchers divulge new PI3K-alpha inhibitors

Nov. 22, 2021

Recurium IP Holdings presents new PROTACs for cancer

Nov. 22, 2021

Eli Lilly patents new Ret inhibitors

Nov. 22, 2021

Fochon Pharmaceuticals patents Bcl-2 inhibitors

Nov. 22, 2021

Biopolar Hongye (Nantong) Pharmaceutical synthesizes JAK2 inhibitors

Nov. 19, 2021

Beijing Tide Pharmaceutical identifies GTPase KRAS inhibitors

Nov. 19, 2021

Betta Pharmaceuticals patents new compounds for cancer

Nov. 19, 2021

Hangzhou Innogate Pharma divulges SYK and JAK2 kinase inhibitors

Nov. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.